EcoDrugPlus

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSDORG00000008271
Gene Symbol: PTPN11
3 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSDORG00000011204
Gene Symbol: PTPRB
4 Cross references
268 Possible Orthologues:

Protein-Tyrosine Kinase 6-Like

Ensembl ID : ENSDORG00000004529
Gene Symbol: LOC105996317
4 Cross references
174 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSDORG00000000238
Gene Symbol: PNP
3 Cross references
123 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSDORG00000009012
Gene Symbol: P2RX3
4 Cross references
272 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSDORG00000000159
Gene Symbol: P2RY1
4 Cross references
191 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSDORG00000016443
Gene Symbol: P2RY12
4 Cross references
182 Possible Orthologues:

Purinergic Receptor P2y2

Ensembl ID : ENSDORG00000014962
Gene Symbol: P2RY2
4 Cross references
200 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSDORG00000027667
Gene Symbol: P2RY4
3 Cross references
168 Possible Orthologues:

Pyrimidinergic Receptor P2y6

Ensembl ID : ENSDORG00000024896
Gene Symbol: P2RY6
4 Cross references
183 Possible Orthologues:

Receptor Activity Modifying Protein 1

Ensembl ID : ENSDORG00000024593
Gene Symbol: RAMP1
3 Cross references
252 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSDORG00000010392
Gene Symbol: RIPK1
3 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).